Felix Keil

6PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2026
Robotic Partial Cystectomy and Extended Pelvic Lymph Node Dissection for Node-Positive Urachal Adenocarcinoma in a 34-Year-Old Woman: A Case Report.

|Jan 13, 2026
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients.

Alexander Scheiter, Simon Mellin, Felix Keil

|Oct 27, 2022
Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA Consortium.

Florian Lüke, Florian Haller, Kirsten Utpatel

|Aug 26, 2022
Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities.

Alexander Scheiter, Frederik Hierl, Ingrid Winkel

|Sep 27, 2021
<i>STRN-ALK</i> Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy.

Valeria Gerthofer, Alexander Scheiter, Florian Lüke

|Sep 26, 2019
ZFP36-FOSB fusion in a haemorrhagic epithelioid and spindle cell haemangioma of bone: is there a family of FOSB-rearranged vascular neoplasms of the bone?

Felix Keil, Wolfgang Dietmaier, Patrick Hoffstetter

Pageof 1

Frequent Collaborators

4 joint publications

Alexander Scheiter

2 joint publications

Florian Lüke

1 joint publications

Atanas Ignatov

1 joint publications

Daniel Heudobler